Hyaluronic Acid 0.2% Application Enhanced Chronic Periodontitis Treatment in Non-surgical Phase

PHASE4CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 21, 2019

Primary Completion Date

September 21, 2019

Study Completion Date

July 31, 2020

Conditions
Chronic Periodontitis, Hyaluronic Acid
Interventions
DRUG

0.2% hyaluronic acid gel

In this split mouth study, 733 periodontal pockets of 28 patients with moderate to severe chronic periodontitis were chosen for investigation. They were divided into 2 groups: control group and experimental group. The experimental group received sub-gingival administration of 1 ml of 0.2% hyaluronic acid gel into each pocket immediately after root planing and then after 1 week, 2 weeks and 3 weeks. Clinical parameters were assessed at baseline and 6 weeks after root planing. Subgingival plaque was assessed at baseline and 6 weeks after root planing. Quantitative real-time PCR for Porphyromonas gingivalis (Pg), Treponema denticola (Td), Fusobacterium nucleatum (Fn) Tannerella forsythia (Tf) were performed at the same time.

Trial Locations (1)

749000

Faculty of Odontostomatology - University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City

All Listed Sponsors
lead

University of Medicine and Pharmacy at Ho Chi Minh City

OTHER

NCT04675385 - Hyaluronic Acid 0.2% Application Enhanced Chronic Periodontitis Treatment in Non-surgical Phase | Biotech Hunter | Biotech Hunter